newsfilter
← Latest News
GlobeNewswire·

Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Top-line data readout for oral AMT-101 Phase 2 MARKET combination trial with anti-TNFα in ulcerative colitis (UC) expected in H1 2022 Top-line data readouts from three additional oral AMT-101 Phase 2 trials, consistent with previous guidance FILL